Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Fecal Microbiota Therapy for Recurrent Clostridium Difficile Infection

NCT02686645 is registered in ClinicalTrials.gov with Queen Elizabeth II Health Sciences Centre as lead sponsor.

NCT NCT02686645
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02686645 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Fecal Microbiota Therapy for Recurrent Clostridium Difficile Infection
Lead sponsor
Queen Elizabeth II Health Sciences Centre
Phase
Phase 2/3
Overall status
Unknown status
Start date
December 31, 2016
Completion date
December 31, 2021
Enrollment
50 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

clostridium difficile infection